Dr. Michael Wallace

New Mayo Clinic research represents a promising step toward identifying biological signals or biomarkers that may aid in early detection.

Artificial intelligence reduced by twofold the rate at which precancerous polyps were missed in colorectal cancer screening, reports Mayo-led research team.